Sign In
Buy CLPBF
$57.28
-2.41 (-4.03%)
At Close: Jun 02, 2026
Coloplast A/S (CLPBF) Q4 2023 Earnings Call Transcript
09:45pm, Sunday, 12'th Nov 2023
Coloplast A/S (OTCPK:CLPBF) Q4 2023 Earnings Conference Call November 9, 2023 5:00 AM ET Company Participants Kristian Villumsen - President and Chief Executive Officer Anders Lonning-Skovgaard - Chie
Coloplast completes the acquisition of Kerecis
09:28am, Thursday, 31'st Aug 2023
Coloplast has completed the acquisition of Kerecis, announced on July 7, 2023, after receiving approval from all relevant authorities and reaching a shareholder acceptance level of 100%
Coloplast A/S - Announcement no. 07/2023 – Coloplast announces completion of offering of 12.2 million new B shares
08:03pm, Tuesday, 29'th Aug 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMIT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMIT
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
02:45pm, Friday, 18'th Aug 2023
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
Coloplast A/S (CLPBF) Q3 2023 Earnings Call Transcript
02:20pm, Thursday, 17'th Aug 2023
Coloplast A/S (OTCPK:CLPBF) Q3 2023 Earnings Call Transcript August 17, 2023 4:30 AM ET Company Participants Kristian Villumsen - President and Chief Executive Officer Anders Lonning-Skovgaard - Chief
Coloplast Finance B.V. - Announcement no.
07:10am, Thursday, 17'th Aug 2023
9M 2022/23 Interim financial results, 9M 2022/23 1 October 2022 - 30 June 2023 Coloplast delivered Q3 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK grew 4% to 6,108 million Organ
Denmark's Coloplast buys Kerecis for up to $1.3 bln
02:57am, Friday, 07'th Jul 2023
Danish medical equipment maker Coloplast has agreed to buy Iceland-based biologic wound care firm Kerecis for up to $1.3 billion, it said on Friday.
Coloplast has signed an agreement to acquire Kerecis, an innovative, fast-growing company in the biologics wound care segment, for up to USD 1.3 billion (around DKK 8.9 billion), of which USD 1.2 bill
Coloplast A/S (CLPBF) Q1 2023 Earnings Call Transcript
10:10am, Friday, 03'rd Feb 2023
Coloplast A/S (OTCPK:CLPBF) Q1 2023 Earnings Conference Call February 3, 2023 5:00 AM ET Company Participants Kristian Villumsen - President and CEO Anders Lonning-Skovgaard - CFO Conference Call Part
Coloplast A/S (CLPBF) CEO Kristian Villumsen on Q3 2022 Results - Earnings Call Transcript
04:19pm, Wednesday, 17'th Aug 2022
Coloplast A/S (OTCPK:CLPBF) Q3 2022 Earnings Conference Call August 17, 2022 9:00 AM ET CompanyParticipants Kristian Villumsen - President & CEO Anders Lonning-Skovgaard - EVP & CFO Conference Call Pa
The Scandinavian Shopping List In A Time Of Bargains
04:04pm, Friday, 03'rd Jun 2022
A list of companies covering some of the world's strongest economies in Scandinavia. Diversification can take place not only across sectors but also across geographies, with opportunities here across
